Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

EGFR

  • You have access
    Epidermal Growth Factor Receptor Expression May Correlate with Survival Through Clinical and Radiological Features of Aggressiveness in Glioblastoma Treated with Radiochemotherapy
    PAOLO TINI, ALFONSO CERASE, GABRIELE CEVENINI, SALVATORE F. CARBONE, CLELIA MIRACCO and LUIGI PIRTOLI
    Anticancer Research July 2015, 35 (7) 4117-4124;
  • You have access
    Patients with Non-small Cell Lung Cancer Analyzed for EGFR: Adherence to Guidelines, Prevalence and Outcome
    MARTIN SANDELIN, ANDERS BERGLUND, MAGNUS SUNDSTRÖM, PATRICK MICKE, SIMON EKMAN, MICHAEL BERGQVIST, STEFAN BERGSTRÖM, HIRSH KOYI, EVA BRANDÉN, CHRISTER JANSON and JOHAN BOTLING
    Anticancer Research July 2015, 35 (7) 3979-3985;
  • You have access
    Immunohistochemical Evaluation of Pulmonary Lymphangioleiomyomatosis
    IRMINA GRZEGOREK, DIDO LENZE, MARIUSZ CHABOWSKI, DARIUSZ JANCZAK, MAŁGORZATA SZOLKOWSKA, RENATA LANGFORT, ANDRZEJ SZUBA and PIOTR DZIEGIEL
    Anticancer Research June 2015, 35 (6) 3353-3360;
  • You have access
    Positive Interplay Between CD3+ T-lymphocytes and Concurrent COX-2/EGFR Expression in Canine Malignant Mammary Tumors
    MARIA ISABEL CARVALHO, ISABEL PIRES, JUSTINA PRADA, ADRIANO FERNANDES FERREIRA and FELISBINA L. QUEIROGA
    Anticancer Research May 2015, 35 (5) 2915-2920;
  • You have access
    Population Stratification Effect on Cancer Susceptibility in an Admixed Population from Brazilian Amazon
    PRISCILLA CRISTINA MOURA VIEIRA, ROMMEL MARIO RODRÍGUEZ BURBANO, DÉBORA CHRISTINA RICARDO OLIVEIRA FERNANDES, RAQUEL CARVALHO MONTENEGRO, SIDNEY EMANUEL BATISTA DOS SANTOS, VINICIUS ALBUQUERQUE SORTICA, PAULO PIMENTEL ASSUMPÇÃO, ÂNDREA KELY CAMPOS RIBEIRO-DOS-SANTOS, ANTÔNIO ALBERTO CARVALHO and NEY PEREIRA CARNEIRO DOS SANTOS
    Anticancer Research April 2015, 35 (4) 2009-2014;
  • You have access
    miR-7 Expression in Serous Ovarian Carcinomas
    ANETA SWIERCZ, MAGDALENA CHECHLINSKA, JOLANTA KUPRYJANCZYK, AGNIESZKA DANSONKA-MIESZKOWSKA, ALINA REMBISZEWSKA, KRZYSZTOF GORYCA, MARIUSZ KULINCZAK, MICHALINA ZAJDEL, MARIA SROMEK and JAN KONRAD SIWICKI
    Anticancer Research April 2015, 35 (4) 2423-2429;
  • You have access
    Co-targeting ER and HER Family Receptors Induces Apoptosis in HER2-normal or Overexpressing Breast Cancer Models
    ASHOK K. CHAKRABORTY, RANEE MEHRA and MICHAEL P. DIGIOVANNA
    Anticancer Research March 2015, 35 (3) 1243-1250;
  • You have access
    Detection of Circulating Tumor Cells in Bladder Cancer Using Multiplex PCR Assays
    IOANNIS LEOTSAKOS, PANAGIOTIS DIMOPOULOS, ELIONA GKIOKA, PAVLOS MSAOUEL, ADRIANOS NEZOS, KONSTANTINOS G. STRAVODIMOS, MICHAEL KOUTSILIERIS and CONSTANTINOS A. CONSTANTINIDES
    Anticancer Research December 2014, 34 (12) 7415-7424;
  • You have access
    Erlotinib Is a Well-tolerated Alternate Treatment for Non-small Cell Lung Cancer in Cases of Gefitinib-induced Hepatotoxicity
    KIMIO YONESAKA, TOMOHIRO SUZUMURA, HIROSHI TSUKUDA, YOSHIKAZU HASEGAWA, TOMOHIRO OZAKI, TAKAMUNE SUGIURA and MASAHIRO FUKUOKA
    Anticancer Research September 2014, 34 (9) 5211-5215;
  • You have access
    Detection of Circulating Tumor Cells in Colorectal and Gastric Cancer Using a Multiplex PCR Assay
    ARISTEIDIS G. VAIOPOULOS, IOANNIS D. KOSTAKIS, ELIONA GKIOKA, KALLIOPI CH. ATHANASOULA, EMMANOUIL PIKOULIS, ALEXANDROS PAPALAMBROS, PANAGIOTIS CHRISTOPOULOS, HELEN GOGAS, GREGORY KOURAKLIS and MICHAEL KOUTSILIERIS
    Anticancer Research June 2014, 34 (6) 3083-3092;

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire